Optimization of ceragenins for prevention of bacterial colonization of hydrogel contact lenses

Investigative Ophthalmology and Visual Science

Volumn 54, Issue 9, 2013, Pages 6217-6223

  Gu, Xiaobo ^a   Jennings, Jacob D ^a   Snarr, Jason ^a   Chaudhary, Vinod ^a   Pollard, Jacob E ^a   Savage, Paul B ^a  

^a N243 Eyring Science Center   (United States)

Author keywords

Antimicrobial peptide mimic; Bacterial biofilm; Bacterial infection

Indexed keywords

ANTIMICROBIAL CATIONIC PEPTIDE; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CERAGENIN; CERAGENIN CSA 120; CERAGENIN CSA 13; CERAGENIN CSA 131; CERAGENIN CSA 134; CERAGENIN CSA 136; CERAGENIN CSA 138; LOTRAFILCON B; PHOSPHATE BUFFERED SALINE; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BIOFILM; CONTACT LENS; COVALENT BOND; CYTOTOXICITY TEST; ELUTION; HYDROGEL; INNATE IMMUNITY; LIMIT OF QUANTITATION; LIPOPHILICITY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

ANTIMICROBIAL PEPTIDE MIMIC; BACTERIAL BIOFILM; BACTERIAL INFECTION;

ANTI-INFECTIVE AGENTS; BIOFILMS; CONTACT LENSES, HYDROPHILIC; EYE INFECTIONS, BACTERIAL; HUMANS; HYDROGEL; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STEROIDS;

EID: 84884575692     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.13-12664     Document Type: Article

References (18)

1. Kolar SS, McDermott AM. Role of host-defense peptides in eye diseases. Cell Mol Life Sci. 2011;68:2201-2213.
2. Behlau I, Gilmore MS. Microbial biofilms in ophthalmology and infectious disease. Arch Opthalmol. 2008;126:1572-1581.
3. Willcox M, Sharma S, Naduvilath TJ, et al. External ocular surface and lens microbiota in contact lens wearers with corneal infiltrates during extended wear of hydrogel lenses. Eye Contact Lens. 2011;37:90-95.
4. Szczotka-Flynn LB, Pearlman E, Ghannoum M. Microbial contamination of contact lenses, lens care solutions, and their accessories: a literature review. Eye Contact Lens. 2010;36: 116-129.
5. White CJ, Tieppo A, Byrne ME. Controlled drug release from contact lenses: a comprehensive review from 1965-present. J Drug Del Sci Tech. 2011;21:369-384.
6. Cole N, Hume EBH, Vijay AK, et al. In vivo performance of melamine as an antimicrobial coating for contact lenses in models of CLARE and CLPU. Invest Ophthalmol Vis Sci. 2010; 51:390-395.
7. Willcox MDP. Review of resistance of ocular isolates of Pseudomonas aeruginosa and staphylococci from keratitis to ciprofloxacin, gentamicin and cephalosporins. Clin Exp Optom. 2011;94:161-168.
8. Gallo RL, Hooper LV. Epithelial antimicrobial defense of the skin and intestine. Nat Rev Immunol. 2012;12:503-516.
9. Yeung ATY, Gellatly SL, Hancock REW. Multifunctional cationic host defence peptides and their clinical applications. Cell Mol Life Sci. 2011;68:2161-2176.
10. Willcox MDP, Hume EBH, Aliwarga Y, et al. A novel cationicpeptide coating for prevention of microbial colonization on contact lenses. J Appl Microbiol. 2008;105:1817-1825.
11. Dutta D, Cole N, Kumar N, Willcox MDP. Broad spectrum antimicrobial activity of melimine covalently bound to contact lenses. Invest Ophthalmol Vis Sci. 2013;54:175-182.
12. Sieprawska-Lupa M, Mydel P, Krawczyk K, et al. Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureusderived proteinases. Antimicrob Agents Chemother. 2004;48: 4673-4679.
13. Lai X, Feng Y, Pollard J, et al. Ceragenins: cholic acid-based mimics of antimicrobial peptides. Acc Chem Res. 2008;41: 1233-1240.
14. Garhwal R, Shady SF, Ellis EJ, et al. Sustained ocular delivery of ciprofloxacin using nanospheres and conventional contact lens materials. Invest Ophthalmol Vis Sci. 2012;53:1341-1352.
15. Hyatt AJT, Rajan MS, Burling K, et al. Release of vancomycin and gentamicin from a contact lens versus a fibrin coating applied to a contact lens. Invest Ophthalmol Vis Sci. 2012;53: 1946-1952.
16. Li C, Budge LP, Driscoll CD, et al. Incremental conversion of outer-membrane permeabilizers into potent antibiotics for Gram-negative bacteria. J Am Chem Soc. 1999;121:931-940.
17. Chin JN, Jones RN, Sader HS, Savage PB, Rybak MJ. Potential synergy activity of the novel ceragenin, CSA-13 against clinical isolates of Pseudomonas aeruginosa, including multi-drug resistant P. aeruginosa. Antimicrob Chemother. 2008;61: 365-370.
18. Harbell JW, Le Varlet B, Marrec-Fairley M, et al. Colipa program on optimization of existing in vitro eye irritation assays for entry into formal validation: technology transfer and intra/ inter laboratory evaluation of epiocular assay for chemicals. Toxicologist. 2009;108:79.